The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (7 analysts) rates it buy, with a mean price target of $29.
First Busey Corporation
BUSE · Nasdaq · USD · Market cap $2.4B · 1,832 employees
First Busey Corporation operates as the bank holding company for Busey Bank that engages in the provision of retail and commercial banking products and services to individual, corporate, institutional, and governmental c…
FAIL · Does not pass the screenScreen close, 2026-09-29 · not a live quote
Last reviewed 9 days ago
Screened 2026-09-29 · the tape above runs as of 09:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 29.38 against the desk's fair-value range, base estimate 35.00, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
First Busey Corporation holds its Markdown at $29.38. The statistical read favours the sellers, held for 45 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 45 days |
| Price at the screen | $29.38 |
| Valuation | 11.99 trailing · 10.72 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.70 |
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: bank
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Prohibited keyword in sector/industry: bank | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
First Busey does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-08. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-29 screen. The gold marker is the market price at the same screen. A 19.1% margin of safety to the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits +16% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-29 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsRegional Banks Clear Numbers But Fail Ethics
Picture a Midwest branch handling pay cheques and small business loans. The operation delivers 143% revenue growth and a 28% profit margin while trading at 11.1 times forward earnings. Yet the entire sector trips our ethical screen on day one, so we pass regardless of the modest margin of safety to our 32 dollar fair value.
The business earns a 9% return on equity with an unknown moat and carries the usual regional-bank cyclicality. Low multiples in this industry often signal peak earnings rather than bargains, and seven analysts clustered around the same 32 dollar target add little new insight.
Ethical failure overrides every other data point. We stay away. Analysis, not advice.
| Forward P/E | 10.7xreasonably valued |
| Trailing P/E | 12.0xreasonably valued |
| EPS, trailing | 2.45 |
| EPS, forward | 2.74 |
| Revenue growth | -0.9%revenue is shrinking |
| Profit margin | 29.5%healthy profit margins |
| Return on equity | 9.6%a modest return on shareholder capital |
| Dividend yield | 361.00% |
| Beta | 0.70steadier than the market |
| Short interest, float | 0.06% |
| 52-week range | 22.00 - 31.70 |
| Market cap | $2.4B |
| Employees | 1,832 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBUSE trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (7 analysts) rates it buy, with a mean price target of $29.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (7 analysts) rates it buy, with a mean price target of $29.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (7 analysts) rates it buy, with a mean price target of $29.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 1 Bank Stock Worth Investigating and 2 We Avoid StockStory · 20d ago
- 3 Reasons to Avoid BUSE and 1 Stock to Buy Instead StockStory · 22d ago
- A Look Back at Regional Banks Stocks’ Q2 Earnings: First Busey (NASDAQ:BUSE) Vs The Rest Of The Pack StockStory · 27d ago
- First Busey (BUSE) Could Be a Great Choice Zacks · 29d ago
- First Busey (BUSE) Draws Options Attention, Is The Stock Still Undervalued? Simply Wall St. · 26 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $26.26 | +7.9% | · | $1,079 | +7.9% |
| 2 months | $26.41 | +7.3% | $0.26 | $1,083 | +8.3% |
| 3 months | $24.63 | +15.0% | $0.26 | $1,161 | +16.1% |
| 6 months | $24.54 | +15.4% | $0.52 | $1,175 | +17.5% |
| 1 year | $22.18 | +27.7% | $1.02 | $1,323 | +32.3% |
| 2 years | $20.42 | +38.7% | $2.00 | $1,485 | +48.5% |
| 3 years | $18.58 | +52.5% | $2.96 | $1,684 | +68.4% |
| 5 years | $21.59 | +31.2% | $4.82 | $1,536 | +53.6% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BUSE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.